Vietnam Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Vietnam Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “Vietnam Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Vietnam. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Vietnamese healthcare market offers significant potential for growth due to the increasing elderly population, increasing affordability, and steady economic growth. The 13th National Party Congress approved the 10-year socioeconomic development strategy for 2021-30, defining the goals of accelerating pharmaceutical companies' drug development and manufacturing capabilities, producing high-quality medical instruments, and facilitating research and development (R&D) to produce vaccines and patented drugs by 2030. Vietnam's pharmaceutical market, based on production value, was worth $2.7 billion in 2015, which increased at a CAGR of 10% to $3.6 billion in 2018 in terms of US dollars. The market value is expected to grow further and is forecast to reach $8 billion by 2026. The medical device market of Vietnam is expected to reach $1.8 billion in 2022 from 2017 at a CAGR of 9.6%. In 2019, the medical device market of Vietnam generated revenue of $1.4 billion and became the ninth-largest market in the Asia-Pacific region.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Vietnam, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Novartis, GlaxoSmithKline (GSK), Pfizer, and Sanofi
• Profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Stryker, B. Braun, Terumo, and Getinge
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
• An overview of the opportunities for and challenges to growth in the Vietnamese healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the Vietnamese healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Vietnamese healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership